Legacy Bridge LLC Has $1.52 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Legacy Bridge LLC decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.1% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 16,210 shares of the company’s stock after selling 185 shares during the period. Legacy Bridge LLC’s holdings in GE HealthCare Technologies were worth $1,521,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in GEHC. Osaic Holdings Inc. raised its stake in GE HealthCare Technologies by 29.5% during the first quarter. Osaic Holdings Inc. now owns 168,414 shares of the company’s stock worth $15,282,000 after acquiring an additional 38,352 shares in the last quarter. Ameritas Investment Partners Inc. lifted its stake in GE HealthCare Technologies by 1.4% in the 1st quarter. Ameritas Investment Partners Inc. now owns 17,803 shares of the company’s stock valued at $1,618,000 after purchasing an additional 248 shares during the last quarter. O Shaughnessy Asset Management LLC boosted its position in GE HealthCare Technologies by 19.1% in the first quarter. O Shaughnessy Asset Management LLC now owns 16,090 shares of the company’s stock valued at $1,463,000 after buying an additional 2,577 shares in the last quarter. UniSuper Management Pty Ltd grew its stake in shares of GE HealthCare Technologies by 282.9% during the first quarter. UniSuper Management Pty Ltd now owns 15,193 shares of the company’s stock worth $1,381,000 after buying an additional 11,225 shares during the last quarter. Finally, Lake Street Advisors Group LLC bought a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $211,000. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. Stifel Nicolaus upped their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Wednesday, September 18th. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.36.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $82.72 on Tuesday. The firm’s fifty day simple moving average is $88.65 and its two-hundred day simple moving average is $83.55. GE HealthCare Technologies Inc. has a 12 month low of $66.39 and a 12 month high of $94.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $37.79 billion, a P/E ratio of 22.73, a price-to-earnings-growth ratio of 2.93 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. During the same quarter last year, the firm posted $0.99 earnings per share. The firm’s revenue was up .9% on a year-over-year basis. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.15%. The ex-dividend date was Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.30%.

Insiders Place Their Bets

In other news, CEO Roland Rott sold 3,577 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This represents a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.